Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development

Dave Hoon, Ph.D.
Member and Director
Dept. of Molecular Oncology
John Wayne Cancer Institute
Santa Monica, CA 90404
Mary Knezevich, D.V.M.
Research Veterinarian
Animal Resources Center
Centro Medico
University of Puerto Rico
Riopiedras, PR 00935
Kyung Dall Lee, Ph.D.
Assistant PrIfessor
Dept. of Pharmaceutics
University of Michigan
College of Pharmacy
Ann Arbor, MI 48109-1065
Shoshana Levy, Ph.D.
Professor of Research
Dept. of Medicine
Div. of Oncology
Stanford University
Stanford, CA 94305-5306
Yang Liu, Ph.D.
Associa ro esso
D. of Pathology
ew York University M ical Center
New York, NY 1001t6
Mark Newman, Ph.D.
Vice President
Research and Development
Vaxcel, Inc.
Norcross, GA 30092
Susan Plaeger, Ph.D.
Associate Professor
SDept of Microbiology & Immunology
University of California
School of Medicine
Los Angeles, CA 90095-1752
Gerald Quinnan, M.D.
Pr essor
of Preventive Medicine
Uniformed Services University
of the Health Sciences
Bethesda, MD 20814

PAGE
Yvonne J. Rosenberg, Ph.D.
President
Ther mm
Washington, DC 20009
John J. Rossi, Ph.D.
Director
Dept. of Molecular Biology
Beckman Research Institute of the
City of Hope National Med. Center
Duarte, CA 91010

53

Arnold C. Satterthwait, Ph.D.
Assistant Professor
Dept. of Molecular Biology
The Scripps Research Institute
La Jolla, CA 92037 -

John H. Shiver, Ph.D.
Senior Research Fellow
Dept. of Virus and Cell I
Merck and Co., Inc.
West Point, PA 19486
Iwona Stroynowsky, Ph.D.
Associate Professor
Dept. of Micriobiology
University of Texas
Sou west Medical Center
Dallas, TX 75235

Bi ology

9
44

Vicki Traina-Dorge, Ph.D.
Associate Scientist
Dept. of Microbiology
Tulane University
Regional Primate Research Center
Covington, L
dmund C. Tramont, M.D.
Professor and Dir
edica iotechnology Center.
University of Maryland
School of Medicine
Baltimore, MD 21201
Dennis H. Trent, Ph.D.,
Science Director
Dept. of Scientific Services
Franklin Covey Company, Inc.
Salt Lake City, UT 84119